<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">ESRF BLOCK ALLOCATION GROUP EXPERIMENT REPORT</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Samama</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Gif sur Yvette</orgName>
								<orgName type="institution" key="instit1">CNRS-Toulouse Y. Mechulam Ecole Polytechnique-Palaiseau</orgName>
								<orgName type="institution" key="instit2">CNRS</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">F</forename><surname>Rey</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Gif sur Yvette</orgName>
								<orgName type="institution" key="instit1">CNRS-Toulouse Y. Mechulam Ecole Polytechnique-Palaiseau</orgName>
								<orgName type="institution" key="instit2">CNRS</orgName>
							</affiliation>
						</author>
						<title level="a" type="main">ESRF BLOCK ALLOCATION GROUP EXPERIMENT REPORT</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">4BB54CA52ABA190D530FF0319A8CC662</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-22T16:26+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Shift usage since last Review: Allocated 9 Used 9 Cancelled by Users 0 Cancelled by ESRF 0 Total Number of Visits 3 Total Number of Visitors 11 BAG Principle Investigators (indicate by # those left since last review, * those new since last review.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Protein Name a Data set $ Beam-line Date Protein size Unit cell dimensions ( , o ) Space Group Crystal size (mm 3 ) Anom. Scatt.(s)) dmin ( ) Rsym (%) Structure Status b Publication Status c Comments eIF2gamma GD235-GDP FORMLI STEDER OUL FORMLIS TEDEROU L FORMTEX TE 1 oct 2001 43 kD 51.5,87,58, 110, 90, 110,90 P21 0.3,0.1,0.05 2 3.9 completed in press soaking eIF2gamma GD235-GDPNP ligand ID14-EH1 1 oct 2001 43 kD 51.5,87,58, 110, 90, 110,90 P21 0.3,0.1,0.05 1.8 4.3 completed in press co-crystallized eIF2gamma GD235-GDP ligand ID14-EH1 1 oct 2001 43 kD 51.5,87,58, 110, 90, 110,90 P21 0.2,0.06,0.03 2.1 5.7 completed in press co-crystallized eIF2gamma GD235-GDPNP ligand ID14-EH1 1 oct 2001 43 kD 51.5,87,58, 110, 90, 110,90 P21 0.3,0.1,0.05 2.2 5.0 completed in press soaking eIF2gamma -GDP ligand ID14-EH1 1 oct 2001 43 kD 51.5,87,58, 110, 90, 110,90 P21 0.15,0.06,0.0 3 1.9 3.8 completed in press soaking eIF2gamma GD235-ATP irrelevant ID14-EH1 1 oct 2001 43 kD 51.5,87,58, 110, 90, 110,90 P21 0.3,0.1,0.05 2.1 6.0 solved in process ligand not seen MetRS P.abyssi native ID14-EH1 13 feb 2002 84 kD 117,117,288,90,90,90 I4122 0.2,0.05,0.03 4.5 8.0 solved in process MetRS P.abyssi native ID14-EH1 13 feb 2002 84 kD 117,117,288,90,90,90 I4122 0.2,0.05,0.03 2.9 8.7 solved in process MetRS-E.coli-DFM native ID14-EH1 13 feb 2002 64 kD 78,45,86,90,107,86 P21 0.4,0.4,0.03 1.7 5.2 under refinement in process Herpesvirus-gD as a fusion protein with antibody fragment MIR ID14-EH1 01-10-01 170 kDa 43 76 103, 90 91.5 90 C2 .2x.1x.03 Pt 3.9 10 under refinement in process HCVpolymerase-GTP-magnesium complex ligand ID14-EH1 01-10-01 62kDa 67 97 96.5, 90 90 90 P21212 .5x.2x.1 1.8 6.7 completed in press HCVpolymerase-GTP-magnesium complex ligand ID14-EH1 17-11-01 62kDa 67 97 96.5, 90 90 90 P21212 .6x.2x.1 1.5 7.2 under refinement in process Capsid protein of Infectious Bursal Disease Virus native ID14-EH1 17-11-01 10x45 kDa 261 261 353 90 90 120 P6322 .2 x .2 x .02 7 10 under refinement in process Fusion protein of Sindbis Virus native ID14-EH1 17-11-01 43kDa 34 75 206, 90 90 90 P212121 .1x.08x.02 3.4 7.8 solved in process Fab against gD of Herpesviruses ligand ID14-EH1 13-02-02 50 kDa 45.5 68 71, 90 106.4 90 P21 .4x.1x.05 1.7 6.9 solved in process HCVpolymerase-inhibitor complex ligand ID14-EH1 13-02-02 62kDa 67 97 96.5, 90 90 90 P21212 .3x.1x.1 1.9 7.5 under refinement in process Complex between antibody fragment and rheumatoid factor native ID14-EH1 13-02-02 100kDa 242 76 103, 90 91.5 90 C2 .2x.1x.03 3 6.9 under refinement in process Capsid protein of Infectious Bursal Disease Virus native ID14-EH1 13-02-02 10x45 kDa 261 261 353 90 90 120 P6322 .2 x .2 x .1 4 9 solved in process native ID14-EH1 solved submitted FlhDC semeth E. coli native ID14-EH1 01-10-01 70 kD 85.2, 125.2, 179.03 90, 90, 90 I222 0.08x0.06x 0.06 Se 4.5 8.5 under refinement in process FlhDC Salty native ID14-EH1 01-10-01 70 kD 150.5, 150.5, 115.9, 90, 90, 120 P61 0.05x0.05x 0.5 0 3.5 7.5 under refinement in process YycG AMPPNP SAD ID14-EH4 17-11-01 18 kD 38.75, 48.52, 43.20 90, 112.54, 90 P21 0.15x0.04x 0.04 Zn 1.5 5.4 solved in process Oxa-10 K70A mutant ID14-EH4 17-11-01 55 kD 79.1, 79.1, 105.4 90, 90, 120 P31 0.15x0.23x 0.1 0 2.2 7.1 solved in process PleC-DivK Caucr native ID14-EH1 13-02-02 60 kD 171.5,171.5,255 90, 90, 120 P3 0.26x0.26x0. 2 0 3.7 8.3 under refinement in process XCL Xerch native ID14-EH1 13-02-02 63 kD 83.8,83.8,71.5 90, 90, 120 P622 0.14x0.12x0. 12 0 2 9.8 under refinement in process native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted</p><p>a Include name of substrate/inhibitor ligand if applicable. b either "solved", "under refinement" or "completed". c Choose "submitted", "in press" or "published" as necessary. Also state if data set proved unusable or irrelevant and give reason under comments. $ Data set: describe as native, ligand, mutant, MAD, SAD, MIR.</p><p>Protein Name a Data set $ Beam-line Date Protein size Unit cell dimensions ( , o ) Space Group Crystal size (mm 3 ) Anom. Scatt.(s)) dmin ( ) Rsym (%) Structure Status b Publication Status c Comments native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted native ID14-EH1 solved submitted</p><p>a Include name of substrate/inhibitor ligand if applicable. b either "solved", "under refinement" or "completed". c Choose "submitted", "in press" or "published" as necessary. Also state if data set proved unusable or irrelevant and give reason under comments. $ Data set: describe as native, ligand, mutant, MAD, SAD, MIR.</p></div>		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0" />			</div>
			<div type="references">

				<listBibl/>
			</div>
		</back>
	</text>
</TEI>
